• FirefoxInstall the new Firefox »
  •  Dow Down 1.54% Nasdaq Down 1.11%

    Ariad Pharmaceuticals Inc. (ARIA)

    -NasdaqGS
    8.08 Down 0.17(2.06%) 4:00PM EST
    |After Hours : 8.14 Up 0.06 (0.74%) 7:56PM EST
    Add to Portfolio
    Prev Close:8.25
    Open:8.22
    Bid:7.97 x 200
    Ask:8.50 x 2000
    1y Target Est:8.35
    Beta:1.22
    Earnings Date:May 5 - May 11 (Est.)
    Day's Range:8.06 - 8.30
    52wk Range:4.90 - 8.72
    Volume:6,174,300
    Avg Vol (3m):6,435,390
    Market Cap:1.52B
    P/E (ttm):N/A
    EPS (ttm):-0.87
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ARIADown 2.06%1.52B
    NVSDown 1.51%233.77B
    PFEDown 1.45%208.20B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):14.68
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.03
    Quarterly EPS Est (Mar-15) :-0.26
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):-0.19

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ARIAD Pharmaceuticals, Inc., an oncology company, is engaged in the discovery, development, and commercialization of medicines for cancer patients. It offers Iclusig (ponatinib), a tyrosine kinase inhibitor for the treatment of adult patients with... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback